Who are Bacille Calmette Guerin (BCG)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): varicella-3, Live attenuated HAV vaccine, Zostavax vaccine, Herpes Zoster, Herpes Zoster Vaccine, Live, Attenuated Hepatitis A Vaccine, H2 Strain.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bacille-calmette-guerin-bcg.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Bacille Calmette Guerin (BCG) — Competitive Intelligence Brief

Bacille Calmette Guerin (BCG) (Bacille Calmette Guerin (BCG)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology, Oncology, Infectious Disease.

marketed Live attenuated vaccine Immunology, Oncology, Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Bacille Calmette Guerin (BCG) (Bacille Calmette Guerin (BCG)) — Bandim Health Project. BCG is a live attenuated mycobacterial vaccine that stimulates innate and adaptive immune responses to enhance anti-tumor and anti-infectious immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Bacille Calmette Guerin (BCG) TARGET	Bacille Calmette Guerin (BCG)	Bandim Health Project	marketed	Live attenuated vaccine
varicella-3	varicella-3	Beijing Center for Disease Control and Prevention	marketed	Live attenuated vaccine	Varicella-zoster virus
Live attenuated HAV vaccine	Live attenuated HAV vaccine	Sinovac Biotech Co., Ltd	marketed	Live attenuated vaccine
Zostavax vaccine	Zostavax vaccine	Oklahoma Medical Research Foundation	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
Herpes Zoster	Herpes Zoster	Canadian Immunization Research Network	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
Herpes Zoster Vaccine, Live	Herpes Zoster Vaccine, Live	Changchun BCHT Biotechnology Co.	marketed	Live attenuated vaccine
Attenuated Hepatitis A Vaccine, H2 Strain	Attenuated Hepatitis A Vaccine, H2 Strain	Jiangsu Province Centers for Disease Control and Prevention	marketed	Live attenuated vaccine	Hepatitis A virus

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bacille Calmette Guerin (BCG) — Competitive Intelligence Brief. https://druglandscape.com/ci/bacille-calmette-guerin-bcg. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab